Tech Company Financing Transactions
Retia Medical Funding Round
Retia Medical closed a $7 million Series A funding round on 8/17/2012. Backers included Pritzker Group Venture Capital and private investors.
Transaction Overview
Company Name
Announced On
8/17/2012
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Series A
Investors
Pritzker Group Venture Capital (Lead Investor)
Proceeds Purpose
Using the proceeds from this Pritzker/Vlock family office financing, Retia will complete product development, submit regulatory filings and launch its minimally invasive, cardiac output monitor.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
7 Dana Rd. 111
Valhalla, NY 10595
USA
Valhalla, NY 10595
USA
Phone
Website
Email Address
Overview
Retia Medical develops monitors for high-risk patients. Retia's first product monitors cardiac output, a critical health metric that indicates the flow rate of blood pumped by the heart. The initial target market for this technology is the ICU and operating rooms. It is potentially extendable for use in emergency rooms or at home.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Marc Zemel
Chief Technical Officer
Ramakrishna Mukkamala
Executive Vice President
Jerry Korten
VP - Engineering
Alexander Markovic
Browse more venture capital transactions:
Prev: 8/17/2012: Fandeavor venture capital transaction
Next: 8/17/2012: Apixio venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record funding rounds that are announced publicly. VC investment data records reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs